Skip to main content

Sub menu

News and Community
About us

Search

Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

You are here

Home
Guidance and resources
Sponsors

BPPR Consulting

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (9)

Date

2022 (9)

Results for "[search-keyword]"

Search

Sponsor content

9 result(s) found, displaying 1 to 9

MIN-I-JET NALOXONE 800microgram/2mL injection syringe with needle Cancelled under Section 30(1)(c) of the Act

28 March 2022

Cancellation by sponsor

Requested by BPPR Consulting
MIN-I-JET LIGNOCAINE HYDROCHLORIDE 100mg/5mL injection syringe Cancelled under Section 30(1)(c) of the Act

28 March 2022

Cancellation by sponsor

Requested by BPPR Consulting
MIN-I-JET GLUCOSE 25g/50mL injection syringe Cancelled under Section 30(1)(c) of the Act

28 March 2022

Cancellation by sponsor

Requested by BPPR Consulting
MIN-I-JET CALCIUM CHLORIDE 10% w/v 1g/10mL injection syringe Cancelled under Section 30(1)(c) of the Act

28 March 2022

Cancellation by sponsor

Requested by BPPR Consulting
MIN-I-JET ATROPINE SULFATE 1mg/10mL injection syringe Cancelled under Section 30(1)(c) of the Act

28 March 2022

Cancellation by sponsor

Requested by BPPR Consulting
MIN-I-JET SODIUM BICARBONATE 4.2g/50mL injection syringe Cancelled under Section 30(1)(c) of the Act

28 March 2022

Cancellation by sponsor

Requested by BPPR Consulting
MIN-I-JET NALOXONE 400microgram/1mL injection syringe Cancelled under Section 30(1)(c) of the Act

28 March 2022

Cancellation by sponsor

Requested by BPPR Consulting
MIN-I-JET NALOXONE 2mg/5mL injection syringe with needle Cancelled under Section 30(1)(c) of the Act

28 March 2022

Cancellation by sponsor

Requested by BPPR Consulting
MIN-I-JET ADRENALINE 1:10000 1mg/10mL injection pre-filled syringe Cancelled under Section 30(1)(c) of the Act

28 March 2022

Cancellation by sponsor

Requested by BPPR Consulting

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.

© Commonwealth of Australia